DHER34:BVMF
Danaher Corporation Bdr
R$46.55
0.00%
(0.00) 1H
9 Nov, 5:53:51 PTG GMT-3 · BRL
search
Semua simbol
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk DHER34...
Buka
R$46.40
Tinggi
R$46.55
Rendah
R$46.40
Permodalan Pasaran
165.41B
Purata volum
1.95K
Volum
168.00
tgi 52 mgu
R$47.00
rdh 52 mgu
R$27.94
Syer tertunggak
703.53J
Bilangan pekerja
59K
Buka
R$46.40
Tinggi
R$46.55
Rendah
R$46.40
Permodalan Pasaran
165.41B
Purata volum
1.95K
Volum
168.00
tgi 52 mgu
R$47.00
rdh 52 mgu
R$27.94
Syer tertunggak
703.53J
Bilangan pekerja
59K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Yahoo Finance
·
3 jam lalu
Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in Focus
TradingView
·
9 jam lalu
DHR: Growth strategy centers on share gains, innovation and cross-selling, with reshoring revenue from 2028 onward
Investing.com
·
10 jam lalu
Danaher at UBS Global Healthcare Conference: growth plan takes shape
Investing.com Canada
·
10 jam lalu
Form 144 DANAHER CORP /DE/ For: 9 November By Investing.com
Profil
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
Perihal Danaher Corporation Bdr